M. Alhamdan

Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial

T. Madani, A. Koshak, S. Wali, 2021, Complementary Therapies in Medicine.

Attitudes toward the SARS-CoV-2 Vaccine: Results from the Saudi Residents’ Intention to Get Vaccinated against COVID-19 (SRIGVAC) Study

N. Alhakamy, M. Baig, Hani Asfour, 2021, Vaccines.

Piceatannol-Loaded Bilosome-Stabilized Zein Protein Exhibits Enhanced Cytostatic and Apoptotic Activities in Lung Cancer Cells

Giuseppe Caruso, N. Alhakamy, S. M. Badr-Eldin, 2021, Pharmaceutics.

Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial

T. Madani, A. Koshak, S. Wali, 2020, Trials.

Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial

T. Madani, A. Koshak, S. Wali, 2021, European Journal of Integrative Medicine.

Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Clinical Trial (RCT)

T. Madani, A. Koshak, S. Wali, 2020 .